SUNGKYUNKWAN UNIVERSITY SCHOOL OF MEDICINE

CLOSE HEADER

Seminar

Notice : Number, Title, Inquiries, Writer, Date, Attached file
No. Title Inquiries Writer Attached File
194 (2026, Fall)(Week 3) Bi-directional functional genomics screening for mapping extracellular interactions 24 BK21
193 (2026, Fall)(Week 2) Diet and pharmacological interventions for obesity and metabolic disorders 46 BK21
192 (2026, Fall)(Week 1) 3D multi-omic mapping of tumors for precision oncology 62 BK21
191 (24 JUL 2026) Toward Interpretable and Generalizable AI for Regulatory Genomics 142 BK21
190 (6 JUL 2026) Structural principles of transcription factor decoding by the Mediator complex 129 BK21
189 (1 JUL 2026) Stem cell plasticity and niche remodeling in tissue regeneration and early tumor development 142 BK21
188 (2 JUL 2026) What can(’t) machine learned biology do? 146 BK21
187 (26 JUN 2026) Exploring Disease-associated Liver Metabolism using Cutting-Edge Metabolomics 172 BK21
186 (25 JUN 2026) Membrane Cholesterol Refinement: From General Lipid Principles to Synaptic Precision 166 BK21
185 (22 JUN 2026) Human assembloid model of the ascending neural sensory pathway 155 BK21
184 (18 JUN 2026) Polypept(o)ides: From Novel Materials to Cancer Therapies 140 BK21
183 (17 JUN 2026) mRNA vaccines engage unconventional pathways in CD8+ Tcell priming 139 BK21
182 (2026, Spring)(15th) BK21 Postdoc Presentation Seminar & Final Week 152 BK21
181 (2026, Spring)(14th) Microbiome-gut-brain axis in the pathogenesis and sexual dimorphism of ALS 656 BK21
180 (2 JUN 2026) Early-Life Oral Microbiome Development: Novel Species and their Function in Infant Oral Communities 173 BK21
179 (2026, Spring)(13th) BK21/MRC Seminar & Joint Symposium(10 AM) 187 BK21
178 BICS Distinguished Lecture & Nexus Forum (5/21(Thu)14:00) 258 BK21
177 (21 MAY 2026) RNA metabolism in aging and aging-associate diseases 209 BK21
176 (2026, Spring)(12th) Decoding muscle stem cell aging programs for rejuvenation therapy 202 BK21
175 (2026, Spring)(11th) Next-generation therapeutics for inflammatory bowel disease beyond conventional therapies 200 BK21